Publication

Cardiac Resynchronization Therapy for Adult Patients With a Failing Systemic Right Ventricle: A Multicenter Study

Downloadable Content

Persistent URL
Last modified
  • 07/03/2025
Type of Material
Authors
    Rohit K Kharbanda, University Medical CenterJeremy P Moore, Ahmanson UCLA Adult Congenital Heart Dis CtrMichael Lloyd, Emory UniversityRobert Galotti, Ahmanson UCLA Adult Congenital Heart Dis CtrAd JJC Bogers, University Medical Center, RotterdamYannick JHJ Taverne, University Medical Center, RotterdamMalini Madhavan, Mayo ClinicChristopher J McLeod, Mayo ClinicAnne M Dubin, Stanford UniversityDouglas Y Mah, Boston Childrens HospitalPhilip M Chang, University of Florida HealthAnna N Kamp, Nationwide Childrens HospitalJens C Nielsen, Aarhus UniversityAlper Aydin, University of OttawaRonn E Tanel, University of California San FranciscoMaully J Shah, Childrens Hospital of PhiladelphiaThomas Pilcher, University of UtahReinder Evertz, Radboud University NijmegenPaul Khairy, Université de MontréalReina B Tan, New York UniversityRichard J Czosek, Cincinnati Children’s Hospital Medical CenterKalyanam Shivkumar, Ahmanson UCLA Adult Congenital Heart Dis CtrNatasja MS de Groot, University Medical Center, Rotterdam
Language
  • English
Date
  • 2022-11-15
Publisher
  • WILEY
Publication Version
Copyright Statement
  • © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 11
Issue
  • 22
Start Page
  • e025121
End Page
  • e025121
Grant/Funding Information
  • None.
Supplemental Material (URL)
Abstract
  • BACKGROUND: The objective of this international multicenter study was to investigate both early and late outcomes of cardiac resynchronization therapy (CRT) in patients with a systemic right ventricle (SRV) and to identify predictors for congestive heart failure readmissions and mortality. METHODS AND RESULTS: This retrospective international multicenter study included 13 centers. The study population comprised 80 adult patients with SRV (48.9% women) with a mean age of 45±14 (range, 18–77) years at initiation of CRT. Median follow-up time was 4.1 (25th–75th percentile, 1.3– 8.3) years. Underlying congenital heart disease consisted of congenitally corrected transposition of the great arteries and dextro-transposition of the great arteries in 63 (78.8%) and 17 (21.3%) patients, respectively. CRT resulted in significant improvement in functional class (before CRT: III, 25th–75th percentile, II– III; after CRT: II, 25th–75th percentile, II– III; P=0.005) and QRS duration (before CRT: 176±27; after CRT: 150±24 milliseconds; P=0.003) in patients with pre-CRT ventricular pacing who underwent an upgrade to a CRT device (n=49). These improvements persisted during long-term follow-up with a marginal but significant increase in SRV function (before CRT; 30%, 25th–75th percentile, 25– 35; after CRT: 31%, 25th–75th percentile, 21– 38; P=0.049). In contrast, no beneficial change in the above-mentioned vari-ables was observed in patients who underwent de novo CRT (n=31). A quarter of all patients were readmitted for heart failure during follow-up, and mortality at latest follow-up was 21.3%. CONCLUSIONS: This international experience with CRT in patients with an SRV demonstrated that CRT in selected patients with SRV dysfunction and pacing-induced dyssynchrony yielded consistent improvement in QRS duration and New York Heart Association functional status, with a marginal increase in SRV function.
Author Notes
  • Natasja M. S. de Groot, MD, PhD, Unit Translational Electrophysiology, Department of Cardiology, Erasmus Medical Center, Doctor Molewaterplein 40 3015 GD Rotterdam, The Netherlands. Email: n.m.s.degroot@erasmusmc.nl
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items